YZi Labs Responds to CEA Industries' Allegations, Calls Agreement 'Secret' Claim Misleading

CEA Industries Inc. (BNC) has requested confirmation of termination of a purported 'secret side agreement' involving YZi Labs and 10X Capital. This agreement, according to CEA, diverts a portion of 10X Capital's asset management fees to YZi Labs without providing defined services.

YZi Labs has denied the 'secret agreement' characterization, stating the agreement was negotiated and executed with full knowledge of CEA's board and legal counsel. The firm claims the so-called 'secrecy' is misleading and part of a broader effort by CEA to deflect from governance failures.

On December 11, 2025, YZi Labs terminated the Strategic Services Agreement (SSA) with written notice to 10X Capital. The firm asserts that the termination was communicated to the CEA board on December 13, 2025, and that the agreement did not involve payments or affect the renegotiation of the 10X Capital asset management agreement.

CEA's board has raised concerns that the agreement increases costs without commensurate benefits. It has sought to renegotiate the terms of the AMA to improve flexibility in its treasury strategy, claiming the secret side agreement restricts 10X Capital from renegotiating without YZi Labs' consent.

YZi Labs disputes the claim, stating that the SSA was not a barrier to renegotiation and that it had offered to waive fees to reduce costs for CEA. The firm has urged CEA to clarify its misleading statements and disclose Hans Thomas' related-party transactions.

The disagreement has sparked legal and governance scrutiny, with YZi Labs highlighting the need for transparency and the importance of fair shareholder rights. CEA, on the other hand, has emphasized the need for improved corporate governance and accountability.

Why Did This Happen?

The dispute between YZi Labs and CEA Industries centers on control over asset management agreements and corporate governance. CEA's board views the SSA as a hidden cost driver, while YZi Labs insists the agreement was transparent and voluntarily terminated.

The board of CEA has sought to renegotiate the AMA, aiming to reduce management fees and enhance flexibility in treasury operations. However, 10X Capital claims the SSA restricts renegotiation without YZi Labs' consent, adding complexity to the situation.

YZi Labs argues that its termination of the SSA in December 2025 has already removed any impediments to renegotiation. The firm has offered to waive fees under the SSA to reduce costs and improve performance.

What Are Analysts Watching Next?

Analysts are monitoring the outcome of CEA's efforts to confirm the termination of the SSA and initiate negotiations on the AMA. The success or failure of these negotiations could have significant implications for the company's financial strategy.

Market participants are also watching for clarity from CEA on Hans Thomas' related-party transactions, as requested by YZi Labs. These transactions could impact shareholder perceptions and governance standards.

Legal developments are another focal point. Both parties are expected to file documents with the SEC to clarify their positions and potentially resolve disputes. The outcome could set a precedent for similar corporate governance conflicts.

How Might This Affect Shareholders?

Shareholders are likely to be affected by the potential renegotiation of the AMA. If CEA succeeds in reducing management fees, it could improve net returns and enhance operational flexibility.

However, the ongoing dispute highlights governance risks that could affect investor confidence. Shareholders are urged to review SEC filings and other disclosures to understand the implications of the SSA and its termination.

Investor sentiment may also be influenced by the broader context of CEA's financial performance and strategic direction. The company has seen significant institutional buying activity in recent quarters, which could indicate continued support despite governance challenges.